Rhode Island Hospital
Clinical trials sponsored by Rhode Island Hospital, explained in plain language.
-
Can extra doses of an old drug reverse liver scarring?
Disease control Not yet recruitingThis trial tests whether giving praziquantel three times a year, instead of the standard once a year, can improve liver fibrosis (scarring) caused by schistosomiasis in people aged 15-40 in Uganda. Participants with liver fibrosis will be randomly assigned to one of two treatment…
Phase: PHASE2, PHASE3 • Sponsor: Rhode Island Hospital • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a short family intervention curb teen cannabis use and delinquency?
Disease control Not yet recruitingThis study tests whether a six-session family-based intervention can reduce cannabis use and delinquent behavior in youth who are in a juvenile diversion program. The program focuses on improving parenting practices and parent well-being, with youth attending some sessions. Resea…
Phase: NA • Sponsor: Rhode Island Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Blood pressure drug may help preserve insulin in cystic fibrosis
Disease control Not yet recruitingThis study tests whether verapamil, a common blood pressure medication, can help protect insulin-producing cells in people with cystic fibrosis who have early blood sugar problems or diabetes. Participants take verapamil for several weeks, and researchers measure changes in insul…
Phase: PHASE2 • Sponsor: Rhode Island Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Brain pacemaker trial aims to tame severe OCD
Disease control Not yet recruitingThis study tests whether deep brain stimulation (like a pacemaker for the brain) can help people with severe obsessive-compulsive disorder (OCD) that hasn't improved with medication. Four participants will have electrodes implanted and receive stimulation at one of two brain area…
Phase: NA • Sponsor: Rhode Island Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New therapy aims to lift depression in HIV-Positive teens
Symptom relief Not yet recruitingThis study tests an enhanced version of depression treatment (COMBEX) for youth aged 15-24 with HIV. It combines therapy, medication management, and extra support strategies to improve mood and HIV care. Researchers will compare it to standard combination therapy over 72 weeks in…
Phase: NA • Sponsor: Rhode Island Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Can a simple quality check boost HIV testing in busy ERs?
Knowledge-focused Not yet recruitingThis study tests a quality improvement method called SAIA to help emergency departments in Kenya offer more HIV tests to people who often miss out, like men, teens, and key populations. Researchers will compare hospitals that use SAIA with those that don't, measuring how many pat…
Phase: NA • Sponsor: Rhode Island Hospital • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC